These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 3011862)

  • 1. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.
    Zatz R; Dunn BR; Meyer TW; Anderson S; Rennke HG; Brenner BM
    J Clin Invest; 1986 Jun; 77(6):1925-30. PubMed ID: 3011862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.
    Anderson S; Rennke HG; Brenner BM
    J Clin Invest; 1986 Jun; 77(6):1993-2000. PubMed ID: 3011863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.
    Anderson S; Meyer TW; Rennke HG; Brenner BM
    J Clin Invest; 1985 Aug; 76(2):612-9. PubMed ID: 2993362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy.
    Zatz R; Meyer TW; Rennke HG; Brenner BM
    Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5963-7. PubMed ID: 3862110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of glomerular capillary hypertension in experimental diabetes mellitus obviates functional and structural glomerular injury.
    Dunn BR; Zatz R; Rennke HG; Meyer TW; Anderson S; Brenner BM
    J Hypertens Suppl; 1986 Dec; 4(5):S251-4. PubMed ID: 3033178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.
    Remuzzi A; Puntorieri S; Battaglia C; Bertani T; Remuzzi G
    J Clin Invest; 1990 Feb; 85(2):541-9. PubMed ID: 1688888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular abnormalities in long-term experimental diabetes. Role of hemodynamic and nonhemodynamic factors and effects of antihypertensive therapy.
    Fujihara CK; Padilha RM; Zatz R
    Diabetes; 1992 Mar; 41(3):286-93. PubMed ID: 1551488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with Type I (insulin-dependent) diabetes mellitus.
    Rudberg S; Osterby R; Bangstad HJ; Dahlquist G; Persson B
    Diabetologia; 1999 May; 42(5):589-95. PubMed ID: 10333052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic implications of converting-enzyme inhibitors in renal disease.
    Anderson S; Brenner BM
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):81-7. PubMed ID: 3037894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of glomerular hypertension by insulin administration in diabetic rats.
    Scholey JW; Meyer TW
    J Clin Invest; 1989 Apr; 83(4):1384-9. PubMed ID: 2649514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Converting enzyme inhibition and the glomerular hemodynamic response to glycine in diabetic rats.
    Slomowitz LA; Peterson OW; Thomson SC
    J Am Soc Nephrol; 1999 Jul; 10(7):1447-54. PubMed ID: 10405200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short and long term effects of antihypertensive therapy in the diabetic rat.
    Anderson S; Rennke HG; Garcia DL; Brenner BM
    Kidney Int; 1989 Oct; 36(4):526-36. PubMed ID: 2681929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nephron loss on glomerular hemodynamics and morphology in diabetic rats.
    O'Donnell MP; Kasiske BL; Daniels FX; Keane WF
    Diabetes; 1986 Sep; 35(9):1011-5. PubMed ID: 3743905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage.
    Perico N; Amuchastegui CS; Malanchini B; Bertani T; Remuzzi G
    Exp Nephrol; 1994; 2(4):220-8. PubMed ID: 8069658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of diabetic glomerulopathy: hemodynamic considerations.
    Anderson S; Brenner BM
    Diabetes Metab Rev; 1988 Mar; 4(2):163-77. PubMed ID: 3281808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy.
    Cooper ME; Allen TJ; O'Brien RC; Papazoglou D; Clarke BE; Jerums G; Doyle AE
    Diabetes; 1990 Dec; 39(12):1575-9. PubMed ID: 2245881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat.
    Cooper ME; Allen TJ; Macmillan PA; Clarke BE; Jerums G; Doyle AE
    Diabetologia; 1989 May; 32(5):326-8. PubMed ID: 2546846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversing glomerular hypertension stabilizes established glomerular injury.
    Meyer TW; Anderson S; Rennke HG; Brenner BM
    Kidney Int; 1987 Mar; 31(3):752-9. PubMed ID: 3033388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic endothelin receptor blockade prevents both early hyperfiltration and late overt diabetic nephropathy in the rat.
    Ding SS; Qiu C; Hess P; Xi JF; Zheng N; Clozel M
    J Cardiovasc Pharmacol; 2003 Jul; 42(1):48-54. PubMed ID: 12827026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT).
    Diabetes; 2001 Apr; 50(4):843-50. PubMed ID: 11289051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.